Navigation Links
Shire's New Product Portfolio Delivers Strong Quarterly Performance
Date:10/29/2008

se in the treatment of

ulcerative colitis in certain European Union ("EU") countries during

2008 and 2009;

- FIRAZYR(R) (icatibant) which was launched in Germany and the UK in Q3,

following the receipt of marketing authorization from the European

Commission. Launches will continue across Europe as reimbursement

negotiations proceed. FIRAZYR has orphan designation and is the first

hereditary angiodema ("HAE") product to receive approval throughout the

European Union;

- INTUNIV(TM) (guanfacine) for use in children and adolescents

in the US in 2009;

- FOSRENOL(R) (lanthanum carbonate) in the pre-dialysis Chronic Kidney

Disease ("CKD") market in the US in 2009 subject to ongoing discussions

with the FDA regarding regulatory pathway for approval;

- DAYTRANA(R) (methylphenidate transdermal system) for use in

children in the EU in 2009 and adolescents in the US in 2010; and

- Velaglucerase alfa for the treatment of Gaucher disease in

the US and the EU in 2010.

Update on Current Portfolio

VYVANSE(R) (lisdexamfetamine dimesylate) - Attention Deficit and Hyperactivity Disorder ("ADHD")

- The launch of VYVANSE for adult ADHD in June 2008 has helped to make

VYVANSE the third highest prescribed ADHD product in the US. For the

nine months to September 30, 2008 VYVANSE net sales totaled $215.6

million.

- On July 2, 2008 Shire shipped to wholesalers stocks of three additional

dosage strengths (20mg, 40mg and 60mg) for VYVANSE representing product

sales of approximately $24 million. These net product sales have been

recognized into revenue in Q3 2008.

FOSRENOL(R) -Hyperphosphatemia

- FOSRENOL was approved in Japan in October 2008. Shire's out-licensee,

Bayer Yakuhin Limited, is now progressing pricing and reimbursement

negotiations in that ma
'/>"/>

SOURCE Shire Plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care
2. PEAK Surgical Introduces PlasmaBlade(TM) Product Line Extensions for Use in General Surgery
3. Lilly Announces Launch of Color Differentiation System for Humalog(R) and Humulin(R) U-100 Insulin Products in the United States
4. GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology
5. Consumers Looking to Sustainable Food Production to Feed Global Population
6. Contour Products Introduces Groundbreaking Sleep Apnea, Respiratory and Ergonomic Body Comfort Pillows at Medtrade; Self-Explanatory Products Serve Customer Needs, Expand Retailers DME Offerings
7. Glycotex Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing
8. Sustainable Oils Names Scott Johnson as General Manager, Expands Management Team for Camelina Research and Production
9. Ventria Expands Lactoferrin Production
10. China Biologic Products Provides Preliminary Guidance for 2009 of Revenues of $90 to $100 Million and Net Income of $18 to 22 Million
11. Advanced Analytical Technologies, Inc. Expands Into New Office and Production Space
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... 30, 2015 Available in select ... http://www.lespausa.com , Phytomer’s DOUCEUR INTEMPORELLE Restorative Shield ... skin while battling the weakening threat of inflammaging, ... is formulated with star ingredient GLYCOSEA, a complex ... a complex of soothing minerals and trace elements. ...
(Date:4/30/2015)... Kent, WA (PRWEB) April 30, 2015 ... recently developed ultrafiltration membranes, the PX, PY, ... test coupons, sheets, and disks. Designed to ... applications, these new membranes can fill critical process ... effluent hinder downstream processes. , “New regulations on ...
(Date:4/29/2015)... GUELPH, ON , April 29, 2015 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... twelve-month periods ended December 31, 2014. Biorem,s complete fiscal 2014 year-end financial ... FINANCIAL HIGHLIGHTS: 2014 , 2013 , 2014 ... 10,683 , 19,596 Gross profit 1,326 , ... 1,191 , 1,493 , 3,377 , ...
(Date:4/29/2015)... 29, 2015 AlloSource ®, one ... bone, skin and soft-tissue allografts for use in ... healing, announced the launch of AlloSkin™ AC, an ... Medicaid Services (CMS) also moved AlloSkin™ RT, a ... the high-cost category for reimbursement. "AlloSource ...
Breaking Biology Technology:Phytomer introduces DOUCEUR INTEMPORELLE Restorative Shield Cream 2Phytomer introduces DOUCEUR INTEMPORELLE Restorative Shield Cream 3Sterlitech Offers New Ultrafiltration Membranes 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 3Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 4AlloSource Announces New Possibilities In Wound Care 2
... Entrepreneur Anthony ... Directors, IRVINE, Calif., Sept. 5 NeoMatrix, developer of ... to,identify breast cancer risk, announced today that the company has ... enable an expanded,market release of the HALO System, which is ...
... Sept. 5 Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) ... the Bear Stearns 20th Annual Healthcare Conference on September,11, ... Time) at the Grand,Hyatt Hotel in New York City. ... to provide a corporate overview of the,company and its ...
... the Key Problems Faced by Insomniacs, i.e.,Sleep Onset and ... Today at 11:00 am CET (10:00 am UK,time, 5:00 ... Congress in,Australia HAMBURG, Germany and OXFORD, England, September ... the worldsleep07 congress in Cairns, Australia the,details of the ...
Cached Biology Technology:NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test 2NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test 3NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test 4Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference 3Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201 2Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201 3Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201 4
(Date:4/1/2015)... BOSTON , April 1, 2015   Medisafe ... 1.5 million users across iOS and ... has begun integrating biofeedback into the platform to allow ... health outcomes. For the first time, patients will be ... missing a dose impacts important biometrics, such as glucose ...
(Date:3/26/2015)... 26, 2015 The Granite Club, ... and athletic club, today announced it has implemented a ... of movement for members and staff, while restricting access ... process, we selected FST,s IMID Access system because it ... our members and staff, in addition to unparalleled security," ...
(Date:3/24/2015)... BEACH GARDENS, Fla. , March 24, 2015 ... biometric identity management solutions, today announced that its ... premium clothing accessory retailer Goorin Bros . ... The Crossmatch biometrics-based solution secures access to the ... from the increased risk of data breaches. ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2
... Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch ... of MDC and Charit in Berlin-Buch have gained ... and their molecular repertoire. Dr. Max Werth, Katharina ... transcription factor (grainyhead-like 2, Grhl2), which regulates the ...
... PhD student are part of a research team that ... oxygen levels in the oceans high enough to establish ... By examining ancient-ocean sediments, Kurt Konhauser, student ... last glacier to encircle Earth receded, leaving behind glacial ...
... DURHAM, N.H. A major new study that sounds ... the world,s seagrass species are faring somewhat better, says a ... the study. Fred Short, UNH research professor ... was among the 174 scientists who contributed to "The Impact ...
Cached Biology News:New insights into the development of epithelial cells 2UNH's Fred Short adds seagrass data to major conservation study 2
... can be used to label ... covalently bound acridinium NHS ester ... presence of hydrogen peroxide. Acridinium ... used as a detection method ...
... assay (EMSA) is a powerful tool for ... gel shift or gel retardation, the assay ... subjected to electrophoresis, free DNA will migrate ... LightShift Chemiluminescent EMSA Kit is a nonradioactive ...
... The Guava PCA-96 systems provide automated, ... a tray of microcentrifuge tubes. This flexible ... ideal for screening in basic research, target ... Like it's smaller cousin, the Guava PCA-96 ...
... Cellomics KineticScan™ Reader is Cellomics‘ ... Solutions for Cell-based Screening". The ... ability to do both temporal ... physiological processes, dynamic distribution and ...
Biology Products: